Skip to content

Author

Ravand Samaeekia

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Evaluating taletrectinib in the treatment of patients with ROS1 fusion-positive non–small cell lung cancer

ABSTRACT ROS1 fusion-positive non–small cell lung cancer (NSCLC), occurring in 1–2% of patients, represents a rare but clinically important subset. Patients with ROS1 fusion-positive NSCLC are often younger and tend to have little or no history of smoking. Current first-generation tyrosine kinase inhibitors (TKIs) such...

M. Nagasaka, C. Park, Z. Arter et al. · 0 citations
Open access Sep 2026

Comparative Pharmacovigilance Analysis of Safety Signals Among Advanced Prostate Cancer Therapies Using FAERS (FDA Adverse Event Reporting System)

Simple Summary Advanced prostate cancer is treated with several types of medications, including hormone therapies, chemotherapy, targeted therapies, immunotherapy, and radioligand therapy. Although these treatments have been proven effective in clinical trials, less is known about how they perform in routine clinical p...

Z. Ahmed, R. Sayyid, O. Yazdanpanah et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.